Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
The U.S. Supreme Court recently granted certiorari in WesternGeco v. Ion, a case that could have significant ramifications for U.S. patent holders who compete in foreign markets, say attorneys with MoloLamken LLP.
The IP Owners Association says a new rule by the United States Patent and Trademark Office requiring applicants that appeal its decisions to pay the agency’s legal bills creates a "crippling" burden, according to an amicus brief unsealed Monday at the Federal Circuit.
The Federal Circuit on Monday rejected Helsinn Healthcare’s request to stay its ruling invalidating four patents related to an anti-nausea drug while the company seeks to put its case before the U.S. Supreme Court, saying the decision was narrowly tailored and Helsinn didn’t show it faces irreparable injury.
A Palo Alto-based Fenwick & West LLP partner with experience handling intellectual property litigation for clients in the technology and life sciences industries has been chosen to fill a magistrate judgeship in the Northern District of California, the court said Monday.
A Missouri federal judge on Monday ended a suit claiming that Express Scripts Inc. illegally kicked a pharmacy out of its network, finding there wasn’t evidence the benefits manager had anti-competitive motivations for determining the pharmacy violated the terms of their contract.